Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 19,535 | 26,811 | 29,721 | 33,089 | 18,515 |
| Operating Income | -19,535 | -26,811 | -29,721 | -33,089 | -18,515 |
| Interest Expense | 1,116 | 1,918 | 2,446 | 2,077 | 1,566 |
| Other Income | 395 | 425 | 351 | -1,141 | 351 |
| Pre-tax Income | -20,256 | -28,304 | -31,816 | -36,307 | -19,730 |
| Income Tax | -477 | N/A | -3,075 | -5,972 | -3,653 |
| Net Income Continuous | -19,779 | -28,304 | -28,741 | -30,335 | -16,077 |
| Net Income | $-19,779 | $-28,304 | $-28,741 | $-30,335 | $-16,077 |
| EPS Basic Total Ops | -1,160.00 | -1,820.00 | -2,040.00 | -2,760.00 | -2,820.00 |
| EPS Basic Continuous Ops | -1,152.76 | -1,829.56 | -2,033.08 | -2,755.57 | -2,821.76 |
| EPS Diluted Total Ops | -1,160.00 | -1,820.00 | -2,040.00 | -2,760.00 | -2,820.00 |
| EPS Diluted Continuous Ops | -1,152.76 | -1,829.56 | -2,033.08 | -2,755.57 | -2,821.76 |
| EPS Diluted Before Non-Recurring Items | -1,160.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,512 | $-26,788 | $-29,702 | $-33,071 | $-18,503 |